Global Renal Denervation Market is estimated to be US$ 586.19 million by 2030 wi

Posted by NISHA SHAHA on November 29th, 2021

The Global Renal Denervation Market accounted for US$ 32.00 million in 2020 and is estimated to be US$ 586.19 million by 2030 and is anticipated to register a CAGR of 33.70%. Renal denervation is a minimal invasive procedure to treat hypertension which process by causing reduction in nerve activity which decreases blood pressure. Renal artery contains nerves in their wall which are ablated by applying radiofrequency pulses or ultrasound to the renal arteries. High blood pressure which is not treated by medication are resistant hypertension. The development of catheter-based interventional therapies to ablate renal nerve has shown impressive results in treating blood pressure in patients having complaints of resistant hypertension.

The report “Global Renal Denervation Market, By Product (Simplicity Renal Denervation System, Enlightn, Vessix Renal Denervation System, Paradise Renal Denervation System and Iberis Renal Sympathetic Denervation System), By Application (Radiofrequency, Ultrasound, And Micro-Infusion), By End User (Hospitals, Surgical Centers and Clinics) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) – Trends, Analysis, and Forecast till 2030”

Key Highlights:

• In December 2020, ReCor Medical Announces Positive leads to RADIANCE-HTN TRIO Study and Breakthrough Device Designation for Paradise Ultrasound Renal Denervation System.
• In March 2020, Medtronic plc has announced the first-ever clinical data from the SPYRAL HTN-OFF MED Pivotal Trial. The Landmark SPYRAL HTN-OFF MED Pivotal Trial Shows Superiority for Renal Denervation in Patients with High vital sign Compared to Sham Procedure.

Analyst View:

High blood pressure increases the risk of stroke and heart disease, a leading cause of deaths all over the globe and complication of hypertension, death due to stroke; heart failure are anticipated to fuel the target market growth. Increasing cases of uncontrolled and drug-resistant hypertension are expected to fuel the demand for renal denervation. However, stringent regulatory norms and approval process for renal denervation devices and patience discomfort and pain that arises during reimbursements for renal denervation procedure have inhibited the target market growth.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Renal Denervation Market, By Product (Simplicity Renal Denervation System, Enlightn, Vessix Renal Denervation System, Paradise Renal Denervation System and Iberis Renal Sympathetic Denervation System), By Application (Radiofrequency, Ultrasound, And Micro-Infusion), By End User (Hospitals, Surgical Centers and Clinics) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) – Trends, Analysis, and Forecast till 2030”

To know the upcoming trends and insights prevalent in this market, click the link below:

https://www.prophecymarketinsights.com/market_insight/Global-Renal-Denervation-Market-By-1115

Key Market Insights from the report:

The Global Renal Denervation Market accounted for US$ 32.00 million in 2020 and is estimated to be US$ 586.19 million by 2030 and is anticipated to register a CAGR of 33.70%. The Global Renal Denervation Market report segments the market on the basis of product, application, end-user and region.

• Based on product type, the Global Renal Denervation Market is segmented into the simplicity renal denervation system, EnligHTN, vessix renal denervation system, paradise renal denervation system, and iberis renal sympathetic denervation system.
• Based on application, the Global Renal Denervation Market is segmented into radiofrequency, ultrasound, and micro-infusion.
• Based on end-user, the Global Renal Denervation Market is segmented into hospitals, surgical centers and clinics.
• By region, the Global Renal Denervation Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe’s high share is attributed to the early start of this technology in European countries due to large consumption of the target market.